| Literature DB >> 30713578 |
Hadeel A Al-Rawaf1,2, Sami A Gabr1, Ahmad H Alghadir1.
Abstract
Green tea (Camellia sinensis) has many biological activities and may promote diabetic wound healing by regulation of circulating hypoxia responsive microRNAs (HRMs) which triggers the wound repairing process in diabetic and nondiabetic wounds. Thus, in this study, the potential effects of green tea extract (GTE) on the expression of miRNAs; miR-424, miR-199a, miR-210, miR-21, and fibrogenitic markers; hydroxyproline (HPX), fibronectin (FN), and nitric oxide (NO) were evaluated in wounds of diabetic and nondiabetic rats. The animals were topically treated with vaseline, 0.6% GTE, and 5%w/w povidone iodine (standard control). HPX, FN, and NO levels and microRNAs, miR-424, miR-210, miR-199a, and miR-21, were estimated in wound tissues using colorimetric, immunoassay, and molecular PCR analysis. In vitro analysis was performed to estimate active constituents and their antioxidant activities in methanolic green teat extract (GTE). Wounds treated with green tea, a dose of 0.6, healed significantly earlier than those treated with standard vehicle and vaseline treated diabetic wounds. Higher expressions of HRMs, miR-199a, and miR-21, and lower expression of HRMs, miR-424 and miR-210, were significantly reported in tissues following treatment with green tea extract compared to standard control vehicle. The tissues also contained more collagen expressed as measures of HPX, FN, and NO and more angiogenesis, compared to wounds treated with standard control vehicle. Diabetic and nondiabetic wounds treated with green tea (0.6%) for three weeks had lesser scar width and greater re-epithelialization in shorter periods when compared to standard control vehicle. Expression of HRMs, miR-199a, miR-21, and HRMs and miR-424 and miR-210 correlated positively with HPX, fibronectin, NO, better scar formation, and tensile strength and negatively with diabetes. In addition to antidiabetic and antioxidant activities of green tea components, GTE showed angiogenesis promoting activity in diabetic wound healing. In conclusion, Camellia sinensis extracts in a dose of 0.6% significantly promote more collagen and fibronectin deposition with higher expression of NO, promoting angiogenesis process via molecular controlling of circulating hypoxia responsive microRNAs: miR-424, miR-210, miR-199a, and miR-21 in diabetic and nondiabetic wounds. Our results support a functional role of circulating hypoxia responsive microRNAs: miR-424, miR-210, miR-199a, and miR-21 as potential therapeutic targets in angiogenesis and vascular remodeling in diabetic wound healing.Entities:
Year: 2019 PMID: 30713578 PMCID: PMC6332961 DOI: 10.1155/2019/9019253
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Phytoconstituents screening and antioxidant activity of green tea extract (GTE mg/100mg).
| Item | GTE mg/100mg |
|---|---|
| Percentage yield | 18.98% |
|
| |
| Alkaloids | + |
| Flavonoids | + |
| Tannins | + |
| Glycosides | + |
| Triterpenoids | + |
| Carbohydrates | + |
| Steroids | - |
| Saponins | - |
|
| |
| Total polyphenolic content1 | 382.6± 2.7 |
| Total flavonoid content2 | 78.6± 0.81 |
| Epigallocatechin 3-gallate (EGCG) | 32% (w/w) |
|
| |
| Radical scavenging activity (ΒCLA; %) | |
| At cons. of 500 | 89.7% |
| At cons. 1000 | 97.1% |
| Total antioxidant activity (DPPH; %) | 86.3% |
(+/-) presence or absence of phytoconstituents; phytochemical constituents represent as mean ± SD (n = 3). 1Expressed as mg of gallic acid equivalents (GAE)/g of the dry extract. 2Expressed as mg of quercetin equivalents (QE)/g of the dry extract.
Figure 1Photographs represent the percentage of wound closer rates on different postexcision days (4th - -16th). Group I: vaseline treated normal control rats, group II: diabetic rats treated with vaseline, group III: normal control rats treated with vaseline plus 0.6 green tea extract, group IV: diabetic rats treated with vaseline plus 0.6 green tea extract, and group V: diabetic rats treated with betadine 5% w/w povidone iodine cream as standard control.
Effect of green tea extract on % wound contraction and epithelialization period of wound in excision wound model.
| Group | % wound contraction | Epithelialization period (days) | ||||
|---|---|---|---|---|---|---|
| 4th day | 8th day | 12th day | 16th day | Scar area (mm2) | ||
| Group I | 186.8 ± 0.75 | 142.2± 0.98 (25%) | 65.9 ± 2.56 (46%) | 38.7 ±1.23 (63%) | 99.6±3.9 | 20.9 ± 0.65 |
| Group II | 192.2 ± 0.39a | 151±3.4a (21.9 %) | 85.7± 0.98a (41.8 %) | 55.6 ±2.7 (61.9 %)a | 94.8±5.4a | 22.6 ± 0.45b |
| GroupIII | 188.6 ± 0.28 | 132.3±1.5 (34.6%)a | 45.9 ± 1.37 (68 %)b | 28.9 ±1.3 (83.1%)c | 99.8±2.5b | 13.8± 0.23b |
| GroupIV | 194.6 ± 1.2 | 128 ± 1.4 (35.1 %)a | 56.1± 0.98 (66.8%)b | 22.8 ±0.3 (81.9 %)c | 98.6±1.8b | 14.5 ± 0.28b |
| Group V | 193.9 ± .98 | 168 ± 0.45 (16.1 %) | 75.3 ± 1.2 (43.5 %) | 22.8 ±0.3 (78.6%) | 92.3±3.9 | 15.8 ± 1.4 |
aP < 0.05, bP < 0.01, and cP < 0.001. All values are represented as mean ± SD, n = 8 animals in each group. Data were analyzed by one-way ANOVA, followed by Tukey-Kramer Multiple Comparisons Test. Group I: vaseline treated normal control rats, group II: diabetic rats treated with vaseline, group III: normal control rats treated with vaseline plus 0.6 green tea extract, group IV: diabetic rats treated with vaseline plus 0.6 green tea extract, and group V: standard control rats treated with betadine 5% w/w povidone iodine cream.
Figure 2Effect of green tea on tensile strength of skin wounds in incision wound model in Wistar rats. Values are mean ± SEM of 8 rats in each group. aP < 0.05, bP < 0.01, and cP < 0.001 compared to respective control groups (normal and diabetic) and standard. Statistical analysis was done by one-way analysis of variance followed by Tukey-Kramer Multiple Comparisons Test. Group I: vaseline treated normal control rats, group II: diabetic rats treated with vaseline, group III: normal control rats treated with vaseline plus 0.6 green tea extract, group IV: diabetic rats treated with vaseline plus 0.6 green tea extract, and group V: diabetic rats treated with betadine 5% w/w povidone iodine cream as standard control.
Effect of green tea on dry granulation tissue, protein, hydroxyproline, fibronectin, and nitric oxide (NO) in excision wound model.
| Group | Dry weight of tissues | Protein | Fibrogenesis markers | ||
|---|---|---|---|---|---|
| Hydroxyproline | Fibronectin | NO | |||
| Group I | 365.3 ± 12.3 | 56.7 ± 1.9 | 168.2 ± 13.7 | 39.4 ± 1.9 | 61.6 ± 6.1 |
| Group II | 291.5 ± 16.5c | 48.7 ± 3.7c | 146.3 ± 9.4c | 28.1 ± 2.9c | 48.5 ± 5.8c |
| Group III | 536.9 ± 28.5a | 68.3 ± 4.6a | 235.1± 12.7c | 62.4 ± 3.8c | 81.4 ± 2.9c |
| Group IV | 615.2 ± 12.3b | 75.1± 1.8b | 285±16.8c | 89.4 ± 5.7c | 96.8 ± 1.6c |
| Group V | 456.3 ± 11.4 | 70.5 ± 2.8 | 198.6±6.7 | 58.2 ± 1.7 | 79.6 ± 2.5 |
Values are mean ± SEM of 8 rats in each group. aP < 0.05, bP < 0.01, and cP < 0.001 compared to respective control groups (normal and diabetic) and standard. Statistical analysis was done by one-way analysis of variance followed by Tukey-Kramer Multiple Comparisons Test. Group I: vaseline treated normal control rats, group II: diabetic rats treated with vaseline, group III: normal control rats treated with vaseline plus 0.6 green tea extract, group IV: diabetic rats treated with vaseline plus 0.6 green tea extract, and group V: standard diabetic rats treated with betadine 5% w/w povidone iodine cream.
Correlation between the rates of wound closer, scar formation, epithelialization period, tensile strength, and fibrogentic markers in diabetic and nondiabetic rats treated with green tea extract.
| Item | wound closer (% contraction) | Scar formation (mm2) | Epithelialization period (Days) | Tensile strength (g) |
|---|---|---|---|---|
| HPX ( | 0.125b | 0.367b | 0.124b | 0.151b |
| Fibronectin (ng/mL) | 0.53b | 0.48b | 0.98b | 0.75b |
| NO (nM/mg protein) | 0.257b | 0368b | 0.215b | 0.134b |
| Diabetes (HbA1c) | -0.13b | -0.38b | -0.46b | -0.56b |
Data presented as coefficient (R); asignificance at <0.01; bsignificance at <0.001.
Figure 3Expression of miRNAs; miR-424, miR-210, miR-199a, and miR-21 in skin tissues of diabetic and nondiabetic wounds treated with green tea extracts and a standard control. Upregulation of miR-424 and miR-210 and downregulation of miR-199a and miR-21 were reported in wounds of diabetic rats compared to control group treated with vaseline only (GI vs GII; r=0.258, P=0.01). Whoever, in diabetic rats treated with vaseline plus 0.6 green tea extract, miR-199a, and miR-21were significantly upregulated (increased), and miR-424 miR-210 were significantly decreased compared to diabetic rats treated with vaseline only (GIV vsGII; r=0.345, P=0.001), respectively. Also, skin wounds of diabetic rats treated with betadine 5% w/w povidone iodine cream as standard control showed an increase in the expression levels of miR-199a and miR-21 and decline in miR-424 and miR-210 compared to respective control groups (GV vs GI; normal or GII; diabetic, r=0.542 p=0.01). In addition, in normal control rats, skin wound treated with vaseline plus 0.6 green tea extract showed considerable upregualtion in the levels of miR-199a and miR-21 and downregulation of miR-424 and miR-210, respectively (GIII vs GI, r=0.287, p=0.05). Statistical analysis was done by one-way analysis of variance followed by Tukey-Kramer Multiple Comparisons Test. Group I: vaseline treated normal control rats, group II: diabetic rats treated with vaseline, group III: normal control rats treated with vaseline plus 0.6 green tea extract, group IV: diabetic rats treated with vaseline plus 0.6 green tea extract, and group V: diabetic rats treated with betadine 5% w/w povidone iodine cream as standard control.
Correlation between circulating hypoxia responsive microRNAs (HRMs) expression with fibrogentic markers (HPX, NO, and fibronectin), diabetic controls, and wound healing of diabetic skin wound tissues of rats following treatment with green tea extracts and betadine 5% w/w povidone iodine cream as a standard control for three weeks.
| Variables | Whole cohort (qRT-PCR) of miRNAs concentrations (a) | |||||||
|---|---|---|---|---|---|---|---|---|
| miR-424 | miR-210 | miR-199a | miR-21 | |||||
| R | P | R | P | R | P | R | P | |
| HPX ( | 0.41 | 0.01 | 0.26 | 0.01 | 0.54 | 0.001 | 0.68 | 0.001 |
| NO (nM/mg protein) | 0.25 | 0.01 | 0.34 | 0.01 | 0.38 | 0.001 | 0.54 | 0.001 |
| Fibronectin | 0.58 | 0.01 | 0.65 | 0.01 | 0.43 | 0.001 | 0.64 | 0.001 |
| Diabetes (HbA1c) | -0.18 | 0.01 | -0.24 | 0.01 | -0.31 | 0.01 | -0.28 | 0.01 |
| Epithelialization period (Days) | 0.36 | 0.01 | 0.57 | 0.01 | 0.48 | 0.001 | 0.89 | 0.001 |
| wound closer (% contraction) | 0.49 | 0.01 | 0.37 | 0.01 | 0.54 | 0.001 | 0.79 | 0.001 |
| Scar formation | 0.86 | 0.01 | 0.68 | 0.01 | 0.37 | 0.001 | 0.95 | 0.001 |
| Tensile strength (g) | 0.41 | 0.01 | 0.71 | 0.01 | 0.46 | 0.001 | 0.84 | 0.001 |
aData are R (spearman). Abbreviations. HbA1C: glycated hemoglobin A1c, miR: microRNA, and HPX: hydroxyproline